Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
DSNKY DAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I
32.790
-0.870-2.58%
All
YOY
Do not show
Business Unit:JPY
nameYOYOperating income%
Pharmaceutical business--1.04T100.00%
Region Unit:JPY
nameYOYOperating income%
Japan--558.25B53.43%
North Americas--236B22.59%
Europe--138.62B13.27%
Other countries--112.02B10.72%
Company Overview More
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
CEO: Mr. Sunao Manabe
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist